Radiopharm Theranostics RADX
NASDAQ RADX
$2.15 +0.09 (+4.36%)
As of: Sep 10, 2026 · 10:29 AM EDT

Radiopharm Theranostics Ltd (RADX) Other Non Operating Income (2023 - 2025)

Radiopharm Theranostics' (RADX) quarterly Other Non Operating Income came in at -$351646.0 in Q2 2025, up 71.32% year-over-year from -$205256.7 in Q2 2024, and up 71.32% quarter-over-quarter from -$1.2 million in Q2 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Radiopharm Theranostics Ltd (RADX) Other Non Operating Income (2023 - 2025) Analysis & Trends

Radiopharm Theranostics (RADX) has reported Other Non Operating Income for 3 consecutive years, with -$351646.0 the latest figure, recorded in Q2 2025.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -351,646.00
Jun 30, 2024 -1.23 Mn
Jun 30, 2023 -257,251.00